FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Daptomycin Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Fresenius Kabi USA, LLC (New 05/17/2022)

Company Contact Information:
888-386-1300

Presentation	Posting Date	Related Information
350mg (NDC 63323-585-15)	N/A
500mg (NDCs 63323-371-10, 63323-371-19, and 63323-871-15)	N/A

Merck Sharp & Dohme Corp. (New 10/08/2021)

Company Contact Information:
800-672-6372

Presentation	Posting Date	Related Information
500 mg (NDC 67919-011-01)	N/A

Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc. (New 08/02/2022)

Company Contact Information:
800-672-6372

Presentation	Posting Date	Related Information
500 mg (NDC 67919-012-01)	08/02/2022

Pfizer (New 07/26/2022)

Company Contact Information:
844-646-4398

Presentation	Posting Date	Related Information
350 mg lyophilized; 15 mL Single-dose vial (NDC 0409-5933-01)	07/26/2022	Supply expected to exhaust 01Sep2022; Replaced with NDC 0409-0120-01; Discontinuation of the manufacture of the drug.
500 mg lyophilized; 15 mL Single-dose vial (NDC 0409-2757-01)	07/26/2022	Supply expected to exhaust 01Oct2022; Replaced with NDC 0409-0122-01; Discontinuation of the manufacture of the drug.